Print

Treating Advanced Solid Tumors in People with Inherited PTEN Mutations Using the Investigational Drug TAS-117

https://www.facingourrisk.org/research-clinical-trials/study/159/treating-advanced-solid-tumors-in-people-with-inherited-pten-mutations-using-the-investigational-drug-tas-117

Clinicaltrials.gov identifier:
NCT04770246 (https://clinicaltrials.gov/show/NCT04770246)

People with advanced cancer and an inherited PTEN mutation

Study Contact Information:

For additional information, please contact:

Osamu Takahashi, MD, PhD by phone: 609-250-7336 or by email at: [email protected]

About the Study

This study will look at how well the targeted therapy TAS-117 works for treating people with an inherited PTEN mutation and advanced or metastatic solid tumors (excluding primary brain tumors). NOTE: this study is no longer enrolling people.

This Study is Open To:

NOTE: this study is no longer enrolling people.

This Study is Not Open To:

NOTE: this study is no longer enrolling people.

About FORCE

FORCE is a national nonprofit organization, established in 1999. Our mission is to improve the lives of individuals and families affected by adult hereditary cancers.